Showing results (261-270 of 1,289) with videos related to
Sort By:
Pageof 129
Journal of Comparative Effectiveness Research|August 23, 2023
Real-world evidence of eteplirsen treatment effects in patients with Duchenne muscular dystrophy in the USAJoel Iff, Yi Zhong, Edward Tuttle, et al.Journal of Comparative Effectiveness Research|August 16, 2023
Access in all areas? A round up of developments in market access and health technology assessment: part 1Ramiro Gilardino, Catrin Treharne, Silvy Mardiguian, et al.Journal of Comparative Effectiveness Research|August 16, 2023
Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?Jeffrey Frankel, David Staskin, Susann Varano, et al.Journal of Comparative Effectiveness Research|January 23, 2024
Distinguishing cardiac catheter ablation energy modalities by applying natural language processing to electronic health recordsJamie Margetta, Alicia SaleJournal of Comparative Effectiveness Research|December 15, 2023
Improved estimation of overall survival and progression-free survival for state transition modelingPeter C Wigfield, Bart Heeg, Mario OuwensJournal of Comparative Effectiveness Research|December 15, 2023
Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysisKrithika Rajagopalan, Nazia Rashid, Dilesh DoshiJournal of Comparative Effectiveness Research|March 18, 2024
Gastrointestinal adverse effects associated with the use of intravenous oliceridine compared with intravenous hydromorphone or fentanyl in acute pain management utilizing adjusted indirect treatment comparison methodsJoseph Biskupiak, Gary Oderda, Diana Brixner, et al.Journal of Comparative Effectiveness Research|February 28, 2024
Use of interrupted time-series analyses in evaluating health economic outcomes following implementation of multilayer water-tight wound closure in a primary total joint arthroplasty populationZiyu Tan, Joerg Tomaszewski, Brian Po-Han Chen, et al.Journal of Comparative Effectiveness Research|April 3, 2024
The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in HealthChakrapani Balijepalli, Lakshmi Gullapalli, Juhi Joshy, et al.Journal of Comparative Effectiveness Research|April 3, 2024
Comparing the performance of two-stage residual inclusion methods when using physician's prescribing preference as an instrumental variable: unmeasured confounding and noncollapsibilityLisong Zhang, Jim LewseyPageof 129